{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:24:44Z","timestamp":1793953484797,"version":"4.8.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001061","name":"Rebecca L Cooper Medical Research Foundation","doi-asserted-by":"publisher","award":["PG2020883"],"award-info":[{"award-number":["PG2020883"]}],"id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018822","name":"Western Sydney University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008710","name":"Dementia Australia Research Foundation","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100008710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"New South Wales Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"Fight MND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pnpbp.2026.111676","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:09:22Z","timestamp":1774285762000},"page":"111676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility"],"prefix":"10.1016","volume":"146","author":[{"given":"Rose","family":"Chesworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McLemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111676_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173497","article-title":"Blocking the ErbB pathway during adolescence affects the induction of anxiety-like behavior in young adult maternal immune activation offspring","volume":"222","author":"Abu-Ata","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112708","article-title":"Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice","volume":"148","author":"Alegre-Zurano","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115194","article-title":"The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal","volume":"165","author":"Alegre-Zurano","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173290","article-title":"Acute cannabidiol treatment attenuates ethanol-induced place preference and reduces aggressivity in group-housed male rats","volume":"211","author":"Andaloussi","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.schres.2019.02.007","article-title":"Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: preliminary results","volume":"208","author":"Aukst Margetic","year":"2019","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14656566.2016.1114101","article-title":"Pharmacological treatment of schizophrenia with comorbid substance use disorder","volume":"17","author":"Azorin","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8071058","article-title":"The potential of Cannabidiol as a treatment for psychosis and addiction: who benefits most? A systematic review","volume":"8","author":"Batalla","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111676_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0045","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111676_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-007-0721-3","article-title":"Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol","volume":"192","author":"Boucher","year":"2007","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111676_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/neu.2023.53","article-title":"Effects of cannabidiol on reward contextual memories induced by cocaine in male and female mice","volume":"36","author":"Brianis","year":"2024","journal-title":"Acta Neuropsychiatr."},{"issue":"14","key":"10.1016\/j.pnpbp.2026.111676_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142583","article-title":"Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms","volume":"24","author":"Calpe-Lopez","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881120965952","article-title":"Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice","volume":"35","author":"Calpe-Lopez","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109833","article-title":"Cannabidiol as a potential cessation therapeutic: effects on intravenous nicotine self-administration and withdrawal symptoms in mice","volume":"246","author":"Cheeks","year":"2024","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111676_bb0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00213-021-05905-9","article-title":"Cannabidiol (CBD) as a novel treatment in the early phases of psychosis","volume":"239","author":"Chesney","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0080","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41386-025-02175-3","article-title":"Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial","volume":"50","author":"Chesney","year":"2025","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173065","article-title":"Cannabidiol (CBD) reduces cocaine-environment memory in mice","volume":"199","author":"Chesworth","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2011.09.019","article-title":"Cognition in female transmembrane domain neuregulin 1 mutant mice","volume":"226","author":"Chesworth","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068371","article-title":"The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice","volume":"8","author":"Chesworth","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269881120967870","article-title":"Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice","volume":"35","author":"Chesworth","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.931384","article-title":"Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model","volume":"13","author":"Chesworth","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0110","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00213-023-06386-8","article-title":"Impaired extinction of operant cocaine in a genetic mouse model of schizophrenia risk","volume":"240","author":"Chesworth","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111014","article-title":"Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL\/6JArc mice","volume":"133","author":"Chesworth","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"21","key":"10.1016\/j.pnpbp.2026.111676_bb0120","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1523\/JNEUROSCI.6014-10.2011","article-title":"Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine","volume":"31","author":"Choi","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pnpbp.2016.08.006","article-title":"Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia","volume":"72","author":"Clarke","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174094","article-title":"D1-like dopamine receptors in the dentate gyrus mediate cannabidiol\u2019s facilitation of extinction and prevention of reinstatement in methamphetamine-induced conditioned place preference","volume":"256","author":"Danesh","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111676_bb0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.neuroscience.2010.07.042","article-title":"Cognition in transmembrane domain neuregulin 1 mutant mice","volume":"170","author":"Duffy","year":"2010","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010134","article-title":"Possible receptor mechanisms underlying cannabidiol effects on addictive-like behaviors in experimental animals","volume":"22","author":"Galaj","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"167","key":"10.1016\/j.pnpbp.2026.111676_bb0145","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-TH1A and TRPV1 receptor mechanisms","author":"Galaj","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111676_bb0150","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111676_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.183","article-title":"Neuregulin signaling pathway in smoking behavior","volume":"7","author":"Gupta","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111676_bb0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopsych.2012.02.038","article-title":"Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans","volume":"72","author":"Han","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2016.05.013","article-title":"Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum","volume":"784","author":"James","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0170","article-title":"Identification of the risk genes associated with vulnerability to addiction: major findings from transgenic animals","volume":"15","author":"Jordan","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108948","article-title":"Cannabidiol and substance use disorder: dream or reality","volume":"207","author":"Karimi-Haghighi","year":"2022","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111676_bb0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1601-183X.2006.00298.x","article-title":"Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia","volume":"6","author":"Karl","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.04.051","article-title":"Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?","volume":"223","author":"Karl","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2026.111676_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","article-title":"The link between schizophrenia and substance use disorder: a unifying hypothesis","volume":"194","author":"Khokhar","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110390","article-title":"Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice","volume":"111","author":"Ledesma","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111676_bb0205","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/mp.2014.109","article-title":"Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons","volume":"20","author":"Ledonne","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2013.08.013","article-title":"Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder","volume":"111","author":"Liput","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111676_bb0220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-010-1896-6","article-title":"A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice","volume":"211","author":"Long","year":"2010","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111676_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034129","article-title":"Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice","volume":"7","author":"Long","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001854","article-title":"Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence","volume":"16","author":"Long","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2026.111676_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuropharm.2013.04.061","article-title":"Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving","volume":"76","author":"Loweth","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Lujan","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111676_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12778","article-title":"The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake","volume":"25","author":"Lujan","year":"2020","journal-title":"Addict. Biol."},{"issue":"113","key":"10.1016\/j.pnpbp.2026.111676_bb0250","article-title":"CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice","volume":"Mar 8","author":"Lujan","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2017.05.005","article-title":"Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: an exploratory analysis of the PRIDE study","volume":"194","author":"Lynn Starr","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"16","key":"10.1016\/j.pnpbp.2026.111676_bb0265","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00213-015-3937-7","article-title":"Sex differences in the long-lasting consequences of adolescent ethanol exposure for the rewarding effects of cocaine in mice","volume":"232","author":"Mateos-Garcia","year":"2015","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111676_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111676_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.626010","article-title":"Role of Cannabidiol in the therapeutic intervention for substance use disorders","volume":"12","author":"Navarrete","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13150","article-title":"CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice","volume":"27","author":"Navarrete","year":"2022","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0285","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bpsgos.2021.06.014","article-title":"Cannabidiol produces distinct U-shaped dose-response effects on cocaine-induced conditioned place preference and associated recruitment of Prelimbic neurons in male rats","volume":"2","author":"Nedelescu","year":"2022","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0290","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpsychires.2025.06.011","article-title":"Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: targeting D2-like dopamine receptors in the hippocampus","volume":"189","author":"Omidiani","year":"2025","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107360","article-title":"Cannabidiol in the context of substance use disorder treatment: a systematic review","volume":"132","author":"Paulus","year":"2022","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0300","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5152\/pcp.2021.21743","article-title":"The use of cannabidiol in treating psychiatric disorders: a systematic review","volume":"31","author":"Pavel","year":"2021","journal-title":"Psychiatry Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0305","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012021","article-title":"Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission","volume":"3","author":"Pierce","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111676_bb0310","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12640-020-00218-9","article-title":"Cannabidiol prevents the expression of the locomotor sensitization and the metabolic changes in the nucleus Accumbens and prefrontal cortex elicited by the combined Administration of Cocaine and Caffeine in rats","volume":"38","author":"Prieto","year":"2020","journal-title":"Neurotox. Res."},{"issue":"47","key":"10.1016\/j.pnpbp.2026.111676_bb0315","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111676_bb0320","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00213-021-05845-4","article-title":"Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats","volume":"238","author":"Smith","year":"2021","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111676_bb0325","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/342734","article-title":"Neuregulin 1 and susceptibility to schizophrenia","volume":"71","author":"Stefansson","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0330","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fnins.2020.00877","article-title":"A rat model of cocaine-alcohol polysubstance use reveals altered cocaine seeking and glutamate levels in the nucleus accumbens","volume":"14","author":"Stennett","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0269881116655979","article-title":"A functional neuregulin-1 gene variant and stressful life events: effect on drug use in a longitudinal population-representative cohort study","volume":"31","author":"Vaht","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pbr.2015.08.004","article-title":"Animal models of drug relapse and craving: from drug priming-induced reinstatement to incubation of craving after voluntary abstinence","volume":"224","author":"Venniro","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1010478","article-title":"The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia","volume":"16","author":"Visini","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111306","article-title":"Persistent behavioural consequences of chronic adolescent cannabidiol (CBD) in a mouse model with increased susceptibility to \u0394(9)-tetrahydrocannabinol and schizophrenia","volume":"138","author":"Visini","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0355","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice","volume":"23","author":"Viudez-Martinez","year":"2018","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111676_bb0360","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/schbul\/sbp016","article-title":"Substance use disorders in schizophrenia--clinical implications of comorbidity","volume":"35","author":"Volkow","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111676_bb0365","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.biopsych.2006.03.017","article-title":"A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia","volume":"60","author":"Walss-Bass","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41467-020-20552-y","article-title":"Overexpression of neuregulin 1 in GABAergic interneurons results in reversible cortical disinhibition","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2026.111676_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114650","article-title":"Light phase does not affect operant sucrose self-administration in adult male C57BL\/6JAbr mice","volume":"454","author":"Watt","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111676_bb0380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2005.11.030","article-title":"Relapse of methamphetamine-seeking behavior in C57BL\/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration","volume":"168","author":"Yan","year":"2006","journal-title":"Behav. Brain Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:31:43Z","timestamp":1793950303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":76,"alternative-id":["S0278584626000722"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111676","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111676"}}